Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months

Susanna Esposito; Lorenza Pugni; Cristina Daleno; Andrea Ronchi; Antonia Valzano; Domenico Serra; Fabio Mosca; Nicola Principi

doi:10.1542/peds.2010-1920

Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months

Susanna Esposito, Lorenza Pugni, Cristina Daleno, Andrea Ronchi, Antonia Valzano, Domenico Serra, Fabio Mosca, Nicola Principi

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article

Abstract

OBJECTIVE: This study was designed to evaluate the immunogenicity, safety, and tolerability of a monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children aged 6 to 23 months who had different gestational ages (GAs) at birth. METHODS: The study involved 105 children: 35 preterm subjects with a GA of

Original language	English
Journal	Pediatrics
Volume	127
Issue number	5
DOIs	https://doi.org/10.1542/peds.2010-1920
Publication status	Published - May 2011

Keywords

A/H1N1 influenza vaccine
Adjuvants
MF59
Pandemic influenza
Preterm infants

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.2010-1920

Fingerprint Dive into the research topics of 'Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months'. Together they form a unique fingerprint.

Cite this

Esposito, S., Pugni, L., Daleno, C., Ronchi, A., Valzano, A., Serra, D., Mosca, F., & Principi, N. (2011). Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months. Pediatrics, 127(5). https://doi.org/10.1542/peds.2010-1920

@article{445bb66972284dd1a505ea0d7a6258e5,

title = "Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months",

abstract = "OBJECTIVE: This study was designed to evaluate the immunogenicity, safety, and tolerability of a monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children aged 6 to 23 months who had different gestational ages (GAs) at birth. METHODS: The study involved 105 children: 35 preterm subjects with a GA of",

keywords = "A/H1N1 influenza vaccine, Adjuvants, MF59, Pandemic influenza, Preterm infants",

author = "Susanna Esposito and Lorenza Pugni and Cristina Daleno and Andrea Ronchi and Antonia Valzano and Domenico Serra and Fabio Mosca and Nicola Principi",

year = "2011",

month = may,

doi = "10.1542/peds.2010-1920",

language = "English",

volume = "127",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "5",

}

TY - JOUR

T1 - Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months

AU - Esposito, Susanna

AU - Pugni, Lorenza

AU - Daleno, Cristina

AU - Ronchi, Andrea

AU - Valzano, Antonia

AU - Serra, Domenico

AU - Mosca, Fabio

AU - Principi, Nicola

PY - 2011/5

Y1 - 2011/5

N2 - OBJECTIVE: This study was designed to evaluate the immunogenicity, safety, and tolerability of a monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children aged 6 to 23 months who had different gestational ages (GAs) at birth. METHODS: The study involved 105 children: 35 preterm subjects with a GA of

AB - OBJECTIVE: This study was designed to evaluate the immunogenicity, safety, and tolerability of a monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children aged 6 to 23 months who had different gestational ages (GAs) at birth. METHODS: The study involved 105 children: 35 preterm subjects with a GA of

KW - A/H1N1 influenza vaccine

KW - Adjuvants

KW - MF59

KW - Pandemic influenza

KW - Preterm infants

UR - http://www.scopus.com/inward/record.url?scp=79955491362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955491362&partnerID=8YFLogxK

U2 - 10.1542/peds.2010-1920

DO - 10.1542/peds.2010-1920

M3 - Article

C2 - 21464195

AN - SCOPUS:79955491362

VL - 127

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

ER -